Research facility · founded 1898
Roswell Park Comprehensive Cancer Center
Buffalo, United States · roswellpark.org
- Citations, last 5 years
- 77.5k
- Works, last 5 years
- 6 260
- h-index
- 729
- Scientists listed
- 671
- Grants since 2016
- 750
Grants received
2024–2029 · research · R01
MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication
Elizabeth Bouchard · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2024–2026 · research · R21
Combined inhibition of ATR and p110β as Therapy in PTEN-deficient Prostate Cancer
Liya Ding · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Epigenetic aging as a driver of racial disparities in early onset prostate cancer
Bernardo Lemos · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction
Theresa M Busch · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2024–2029 · research · R37
The Immunomodulatory Function of Cyclin E1 in Ovarian Cancer and Therapeutic Targeting
Liya Ding · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2024–2029 · career development · K08
Leveraging small molecule inhibitors to improve CD19 CAR T cell immunotherapy for KMT2A-rearranged ALL
Lisa Madalen Niswander · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2024–2026 · fellowship · F99
Metabolic Reprogramming of Myeloid Cells to Enhance Cancer Immunotherapy
Brian George Morreale · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2025 · research · R03
Identifying the role of interferon and interferon-regulated chemokines in stress-induced immunosuppression in triple negative breast cancer
Shipra Gandhi · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2027 · fellowship · F30
Understanding the role of β2AR-signaling on ILC2 differentiation/plasticity and its implications in cancer progression
Jee Eun Choi · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R50
Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification
Aimee B Stablewski · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Impact of RB activation on the pancreatic cancer epigenome and tumor microenvironment
Erik Knudsen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneichematopoietic cell transplantation
Brian C Betts · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
Charles Stewart Kamen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Induction of interferon response by chromatin damaging anti-cancer therapy
Katerina V Gurova · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R50
Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification
Aimee B Stablewski · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2027 · research · R37
Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma
Ethan Vincent Abel · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer
Boyko S Atanassov · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R35
The Genetic Basis of Human DNA Replication Timing
Amnon Koren · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2027 · research · R37
Novel synthetic lethality strategy for TP53 mutant colorectal cancer
Christos Fountzilas · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2026 · research · R01
Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer
Subhamoy Dasgupta · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
Charles Stewart Kamen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2024 · research · R01
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
Gyorgy Paragh · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2027 · research · R37
Novel synthetic lethality strategy for TP53 mutant colorectal cancer
Christos Fountzilas · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2027 · research · R37
Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma
Ethan Vincent Abel · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
Craig M. Brackett · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2024 · grant · DP2
Decoding the nuclear metabolic processes regulating gene transcription
Subhamoy Dasgupta · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2025 · cooperative agreement · U24
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
Alan David Hutson · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2025 · grant · S10
Acquisition of a calScreener Isothermal Microcalorimetry System for Translational Cancer Metabolism Research at Roswell Park
Elizabeth A Repasky · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2025 · award
Exploiting senomimetic drug effects to improve immunotherapy in breast cancer
John Ebos · Roswell Park Comprehensive Cancer Center · funded by American Cancer Society
2023–2024 · award
Regulation of fibroblast plasticity in pancreatic cancer
Michael Feigin · Roswell Park Comprehensive Cancer Center · funded by American Cancer Society
2023–2028 · research · R01
Impact of RB activation on the pancreatic cancer epigenome and tumor microenvironment
Erik Knudsen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2025 · research · R03
The role of ceramide kinase in metastasis growth from aggressive breast cancer
Nitai Hait · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer
Boyko S Atanassov · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2026 · research · R03
The role of ceramide kinase in metastasis growth from aggressive breast cancer
Nitai Hait · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2025 · fellowship · F31
Examining the impact of laboratory housing temperature on murine CD28 and the response to anti-PD-1
Caitlin M James · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2024 · program · P30
Cancer Data Talks in AI/AN/Native Hawaiian and Indigenous Landscapes
Candace S Johnson · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
Craig M. Brackett · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2025 · fellowship · F31
Examining the impact of laboratory housing temperature on murine CD28 and the response to anti-PD-1
Caitlin M James · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2027 · fellowship · F30
Understanding the role of β2AR-signaling on ILC2 differentiation/plasticity and its implications in cancer progression
Jee Eun Choi · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Induction of interferon response by chromatin damaging anti-cancer therapy
Katerina V Gurova · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
